Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors

  1. Garcia-Carbonero, R.
  2. Bazan-Peregrino, M.
  3. Gil-Martín, M.
  4. Álvarez, R.
  5. Macarulla, T.
  6. Riesco-Martinez, M.C.
  7. Verdaguer, H.
  8. Guillén-Ponce, C.
  9. Farrera-Sal, M.
  10. Moreno, R.
  11. Mato-Berciano, A.
  12. Maliandi, M.V.
  13. Torres-Manjon, S.
  14. Costa, M.
  15. Del Pozo, N.
  16. Martínez de Villarreal, J.
  17. Real, F.X.
  18. Vidal, N.
  19. Capella, G.
  20. Alemany, R.
  21. Blasi, E.
  22. Blasco, C.
  23. Cascalló, M.
  24. Salazar, R.
Journal:
Journal for immunotherapy of cancer

ISSN: 2051-1426

Year of publication: 2022

Volume: 10

Issue: 3

Type: Article

DOI: 10.1136/JITC-2021-003255 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus